Wondering how to use Biopharmaceuticals in a sentence? Below are 10+ example sentences from authentic English texts. Including the meaning .
Biopharmaceuticals meaning
plural of biopharmaceutical
Using Biopharmaceuticals
- The main meaning on this page is: plural of biopharmaceutical
- In the example corpus, biopharmaceuticals often appears in combinations such as: one biopharmaceuticals, biopharmaceuticals in, biopharmaceuticals inc.
Context around Biopharmaceuticals
- Average sentence length in these examples: 21.3 words
- Position in the sentence: 6 start, 12 middle, 2 end
- Sentence types: 20 statements, 0 questions, 0 exclamations
Corpus analysis for Biopharmaceuticals
- In this selection, "biopharmaceuticals" usually appears in the middle of the sentence. The average example has 21.3 words, and this corpus slice is mostly made up of statements.
- Around the word, alder, innovate, ngm, inc, daily and advanced stand out and add context to how "biopharmaceuticals" is used.
- Recognizable usage signals include of alder biopharmaceuticals in the and day one biopharmaceuticals by 59. That gives this page its own corpus information beyond isolated example sentences.
- By corpus frequency, "biopharmaceuticals" sits close to words such as abdulkadir, abed and abhay, which helps place it inside the broader word index.
Example types with biopharmaceuticals
The same corpus examples are grouped by length and sentence type, making it easier to see the contexts in which the word appears:
Citigroup Inc. Acquires 62,985 Shares of Day One Biopharmaceuticals, Inc. (11 words)
Day One Biopharmaceuticals () last released its earnings results on Monday, February 26th. (12 words)
Leerink Swann initiated coverage on Alder Biopharmaceuticals in a report on Tuesday, May 28th. (14 words)
Receive News & Ratings for Innovate Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovate Biopharmaceuticals and related companies with MarketBeat. (33 words)
Renaissance Technologies LLC grew its position in Navidea Biopharmaceuticals, Inc. () by 264.5% in the first quarter, according to the company in its most recent disclosure with the SEC. (29 words)
Illinois is already at the forefront of innovation in technology, biopharmaceuticals, advanced manufacturing, clean energy and more, and we have projects throughout the state ready for investment. (27 words)
Example sentences (20)
Receive News & Ratings for Innovate Biopharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innovate Biopharmaceuticals and related companies with MarketBeat.
Citigroup Inc. Acquires 62,985 Shares of Day One Biopharmaceuticals, Inc.
Connor Clark & Lunn Investment Management Ltd.’s holdings in NGM Biopharmaceuticals were worth $792,000 at the end of the most recent reporting period.
Day One Biopharmaceuticals ( had its price objective reduced by Wedbush from $39.00 to $35.00 in a note issued to investors on Tuesday, reports.
Eiger BioPharmaceuticals, Inc. has a twelve month low of $0.75 and a twelve month high of $9.89.
Franklin Resources Inc. grew its position in Day One Biopharmaceuticals by 59.8% in the second quarter.
Illinois is already at the forefront of innovation in technology, biopharmaceuticals, advanced manufacturing, clean energy and more, and we have projects throughout the state ready for investment.
RegeneRx Biopharmaceuticals has a fifty-two week low of $0.01 and a fifty-two week high of $0.25.
Renaissance Technologies LLC grew its position in Navidea Biopharmaceuticals, Inc. () by 264.5% in the first quarter, according to the company in its most recent disclosure with the SEC.
Day One Biopharmaceuticals, Inc. has a twelve month low of $11.51 and a twelve month high of $18.07.
Day One Biopharmaceuticals () last released its earnings results on Monday, February 26th.
Piper Sandler restated an “overweight” rating and set a $40.00 target price on shares of Day One Biopharmaceuticals in a research note on Monday, July 8th.
The second focuses on industry-specific large-scale AI models in vertical sectors such as biopharmaceuticals, remote sensing, and meteorology.
Cowen restated a “buy” rating and set a $25.00 price objective on shares of NGM Biopharmaceuticals in a report on Monday, May 20th.
Diamond Hill Capital Management Inc. bought a new position in shares of Alder Biopharmaceuticals in the 2nd quarter valued at about $126,000.
Finally, JPMorgan Chase & Co. boosted its position in Eiger Biopharmaceuticals by 103.8% in the 3rd quarter.
Finally, Quantitative Systematic Strategies LLC bought a new position in shares of Alder Biopharmaceuticals in the 2nd quarter valued at about $167,000.
Finally, Vanguard Group Inc. increased its stake in shares of Innovate Biopharmaceuticals by 14.5% in the second quarter.
FNY Investment Advisers LLC purchased a new position in shares of Alder Biopharmaceuticals in the 1st quarter valued at approximately $505,000.
Leerink Swann initiated coverage on Alder Biopharmaceuticals in a report on Tuesday, May 28th.
Common combinations with biopharmaceuticals
These word pairs occur most frequently in English texts:
- one biopharmaceuticals 6×
- biopharmaceuticals in 6×
- biopharmaceuticals inc 5×
- alder biopharmaceuticals 5×
- biopharmaceuticals by 4×
- innovate biopharmaceuticals 3×
- biopharmaceuticals has 3×
- ngm biopharmaceuticals 2×
- eiger biopharmaceuticals 2×
- regenerx biopharmaceuticals 2×